Drugs and Devices

FDA approves new treatment for multiple myeloma

On Nov. 30, the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares